X4 Pharmaceuticals
XFOR
XFOR
56 hedge funds and large institutions have $58.3M invested in X4 Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.16% more ownership
Funds ownership: 1.74% → 1.9% (+0.16%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
44% less call options, than puts
Call options by funds: $123K | Put options by funds: $221K
Holders
56
Holding in Top 10
1
Calls
$123K
Puts
$221K
Top Buyers
| 1 | +$11.2M | |
| 2 | +$5.76M | |
| 3 | +$5.09M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.26M |
| 5 |
SCM
Sio Capital Management
New York
|
+$1.95M |
Top Sellers
| 1 | -$1.9M | |
| 2 | -$206K | |
| 3 | -$44K | |
| 4 |
VF
Virtu Financial
New York
|
-$20K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |